High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy

scientific article published on 01 April 2001

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N
P698PubMed publication ID11315914

P50authorJacob K. SontQ37381820
P2093author name stringBreedveld FC
van Laar JM
van de Putte LB
Bijlsma JW
Fibbe WE
Kruize AA
van den Hoogen FH
Verburg RJ
Barge RM
Preijers F
Petersen EJ
P433issue4
P921main subjectrheumatoid arthritisQ187255
stem cell transplantationQ65592366
P304page(s)754-760
P577publication date2001-04-01
P1433published inArthritis and RheumatismQ23929027
P1476titleHigh-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy
P478volume44

Reverse relations

cites work (P2860)
Q40498732A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation
Q63214396Autologous hematopoietic stem cell transplantation for autoimmune diseases
Q35554404Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry
Q36401901Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study
Q73895232Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma
Q35547252Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders
Q34017756Hematopoietic cell transplantation for Crohn's disease; is it time?
Q26751425Hematopoietic stem cell transplantation for auto immune rheumatic diseases
Q35204112Hematopoietic stem cell transplantation for severe rheumatoid arthritis
Q34744649High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review.
Q34606571High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases
Q24798777Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia
Q94672685Looking for immortality: Review of phytotherapy for stem cell senescence
Q41869348Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration
Q74248344Pharmacoepidemiology and drug safety
Q35091598Prevalence of anti-citrullinated protein antibodies (ACPA) in patients with diffuse large B-cell lymphoma (DLBCL): a case-control study
Q37607071Regulatory T cells as therapeutic targets in rheumatoid arthritis
Q42224815Stem cell therapy: resetting autoimmunity or postponing the inevitable?
Q35558523Stem cell transplantation for multiple sclerosis: What is the evidence?
Q36993217Stem cell transplantation for rheumatic autoimmune diseases
Q37586832Targeted therapies in rheumatoid arthritis: Focus on rituximab.
Q36352913Therapies for rheumatoid arthritis: hope springs eternal